NCT07292311

Brief Summary

This research aims to evaluate the reliability and reproducibility of muscle strength and activation measurement tools, including isokinetic dynamometry and surface electromyography, in patients with chronic kidney disease (CKD). Additionally, the study will assess the feasibility and potential benefits of an online therapeutic exercise program supervised by physiotherapists.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Nov 2025May 2026

Study Start

First participant enrolled

November 7, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 18, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Expected
Last Updated

December 18, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

December 5, 2025

Last Update Submit

December 5, 2025

Conditions

Keywords

chronic kidney diseaserenal patientsmuscle strength assessmentisokinetic testingsurface electromyographyphysiotherapyoccupational therapyfunctional evaluationtherapeutic exercise

Outcome Measures

Primary Outcomes (3)

  • Test-retest reliability of surface EMG (Electromiography) activation.

    RMS (root mean square). microvolts

    7-10 days

  • Test-retest reliability of isokinetic strength

    Intraclass Correlation Coefficient - ICC. Strength (kilograms)

    7-10 days

  • Change in handgrip and limb strength measured by VALD dynamometry

    strength (kilograms)

    Baseline and 12 weeks

Study Arms (2)

Reliability Assessment

ACTIVE COMPARATOR

Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb

Device: Reliability Assessment

Online Therapeutic Exercise

EXPERIMENTAL

8-10 week supervised online program including resistance and mobility exercises

Behavioral: Online Therapeutic Exercise

Interventions

Device: Isokinetic dynamometer and mDurance® surface EMG Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb

Reliability Assessment

Behavioral: Online therapeutic exercise program 8-10 week supervised online program including resistance and mobility exercises

Online Therapeutic Exercise

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old.
  • Diagnosis of chronic kidney disease (hemodialysis, peritoneal dialysis, or kidney transplant).
  • Member of ALCER Association (Badajoz or Cáceres).
  • Medical clearance for physical testing/exercise.

You may not qualify if:

  • Severe cognitive or communication impairment.
  • Unstable cardiovascular or musculoskeletal conditions.
  • Refusal to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultad de Enfermería y Terapia Ocupacional

Cáceres, Cáceres, 10003, Spain

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicMuscle WeaknessSarcopenia

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsMuscular AtrophyAtrophyPathological Conditions, Anatomical

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

December 5, 2025

First Posted

December 18, 2025

Study Start

November 7, 2025

Primary Completion

January 30, 2026

Study Completion (Estimated)

May 15, 2026

Last Updated

December 18, 2025

Record last verified: 2025-11

Locations